Serum Cystatin C as a Biomarker for Early Diabetic Kidney Disease and Dyslipidemia in Young Type 1 Diabetes Patients

Serum Cystatin C as a Biomarker for Early Diabetic Kidney Disease and Dyslipidemia in Young Type 1 Diabetes Patients

<i>Background and objectives:</i> This study aimed to assess the clinical significance of serum cystatin C in the early diagnosis of renal injury and its association with dyslipidemia in young T1D patients. <i>Materials and Methods:</i> A total of 779 subjects were evaluated...

Full description

Bibliographic Details
Main Authors: Ingrida Stankute, Lina Radzeviciene, Ausra Monstaviciene, Rimante Dobrovolskiene, Evalda Danyte, Rasa Verkauskiene
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Medicina
Subjects:
cystatin C
type 1 diabetes
microvascular complication
dyslipidemia
youth
Online Access:https://www.mdpi.com/1648-9144/58/2/218

Internet

https://www.mdpi.com/1648-9144/58/2/218

Similar Items